Cluster group 2 patients had a reduced period of diabetes(5.51 ± 7.61years) and had the lower Rate of patients involving alcohol consumption (21.9%).A larger fraction of patients in cluster group 2 had received diabetes treatment, like non-Sulfonylureas, Glucagon-Like Peptide-1(GLP-1) receptor agonist, Dipeptidyl Peptidase-4(DPP-4) inhibitor, Statins. This evidence concerns the gene GLP1R and diabetes mellitus.